| Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies SS Jatiani, SJ Baker, LR Silverman, EP Reddy Genes & cancer 1 (10), 979-993, 2010 | 326 | 2010 |
| SOX11 augments BCR signaling to drive MCL-like tumor development PY Kuo, SS Jatiani, AH Rahman, D Edwards, Z Jiang, K Ahr, D Perumal, ... Blood, The Journal of the American Society of Hematology 131 (20), 2247-2255, 2018 | 56 | 2018 |
| Dynamin interacts with members of the sumoylation machinery RK Mishra, SS Jatiani, A Kumar, VR Simhadri, RV Hosur, R Mittal Journal of Biological Chemistry 279 (30), 31445-31454, 2004 | 54 | 2004 |
| A Non–ATP-Competitive Dual Inhibitor of JAK2V617F and BCR-ABLT315I Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive … SS Jatiani, SC Cosenza, MVR Reddy, JH Ha, SJ Baker, AK Samanta, ... Genes & cancer 1 (4), 331-345, 2010 | 43 | 2010 |
| Myeloma CAR-T CRS management with IL-1R antagonist anakinra SS Jatiani, A Aleman, D Madduri, A Chari, HJ Cho, S Richard, J Richter, ... Clinical Lymphoma Myeloma and Leukemia 20 (9), 632-636. e1, 2020 | 39 | 2020 |
| Discovery of 2-(1H-indol-5-ylamino)-6-(2, 4-difluorophenylsulfonyl)-8-methylpyrido [2, 3-d] pyrimidin-7 (8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2) MVR Reddy, B Akula, S Jatiani, R Vasquez-Del Carpio, VK Billa, ... Bioorganic & medicinal chemistry 24 (4), 521-544, 2016 | 33 | 2016 |
| Design, synthesis and evaluation of (E)-α-benzylthio chalcones as novel inhibitors of BCR-ABL kinase MVR Reddy, VR Pallela, SC Cosenza, MR Mallireddigari, R Patti, ... Bioorganic & Medicinal Chemistry 18 (6), 2317-2326, 2010 | 31 | 2010 |
| Expression of the antiviral protein MxA in cells transiently perturbs endocytosis SS Jatiani, R Mittal Biochemical and biophysical research communications 323 (2), 541-546, 2004 | 24 | 2004 |
| Conformational analysis of the GTP‐binding protein MxA using limited proteolysis A Varne, K Muthukumaraswamy, SS Jatiani, R Mittal FEBS letters 516 (1-3), 129-132, 2002 | 11 | 2002 |
| SOX11 inhibitors are cytotoxic in mantle cell lymphoma SS Jatiani, S Christie, VV Leshchenko, R Jain, A Kapoor, P Bisignano, ... Clinical Cancer Research 27 (16), 4652-4663, 2021 | 9 | 2021 |
| Jak/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies. Genes Cancer. 2010; 1 (10): 979–93 SS Jatiani, SJ Baker, LR Silverman, EP Reddy PubMedPubMedCentral, 0 | 8 | |
| Inhibiting SOX11-DNA Interaction in Mantle Cell Lymphoma S Christie, S Jatiani, PY Kuo, V Leshchenko, A Kapoor, P Bisignano, ... Blood 128 (22), 1840, 2016 | 3 | 2016 |
| Identification of a dual JAK-2/BCR-ABL kinase inhibitor for treatment of myeloproliferative disorders S Jatiani, S Cosenza, V Pallela, JH Ha, S Baker, MV Reddy, E Reddy CANCER RESEARCH 69, 2009 | 2 | 2009 |
| Aberrant cell cycle programming confers rapid lethality in the EuSOX11+ CCND1 MCL mouse model DR Edwards, P Kuo, A Lagana, S Park, P Nedumaran, V Leshchenko, ... Blood 136, 6-7, 2020 | 1 | 2020 |
| Pharmacokinetics of PLK2 inhibitor GBO-006-1, developed as a novel first-in-class molecule to treat triple negative breast cancer A Roychowdhury, AJ Duraiswamy, S Maddi, C Deb, S Mitra, R Reddy, ... Cancer Research 74 (19_Supplement), 4537-4537, 2014 | 1 | 2014 |
| Discovery of 6-arylsulfonyl pyridopyrimidinones as potent and selective PLK2 inhibitors MM Mallireddigari, V Billa, SS Jatiani, SC Cosenza, EP Reddy, ... Abstr. Pap. Am. Chem. S 243, 1, 2012 | 1 | 2012 |
| Targeting cancer with a selective ATP-mimetic inhibitor of polo like kinase-2 SS Jatiani, SC Cosenza, VK Billa, MVR Reddy, EP Reddy Cancer Research 71 (8_Supplement), 643-643, 2011 | 1 | 2011 |
| Characterization of carbamoyl phosphate synthetase of Streptomyces spp. AG Vaishnav P, Randev S, Jatiani S, Aggarwal S, Keharia H, Vyas PR ... Indian Journal of Experimental Research 38 (9), 931-5, 2000 | 1* | 2000 |
| Sox11 inhibitors for treating mantle cell lymphoma J Jin, M Filizola, A Aggarwal, S Parekh, A Kapoor, SS Jatiani, ... US Patent App. 18/001,516, 2023 | | 2023 |
| Identifying novel substrates of PLK2 using a chemical genetics approach P Ramkumar, RS Levin, M Sansó, S Jatiani, AC Dar, RP Fisher, ... Cancer Research 75 (15_Supplement), 2450-2450, 2015 | | 2015 |
E.Premkumar ReddyProfessor & Director, Mount Sinai School of Medicine, New York, NYVerified email at mssm.edu
